Speedbump, or a Wall? Medidata’s Joe Dustin Talks mHealth in CenterWatch Monthly

Comments
Speedbump, or a Wall? Medidata’s Joe Dustin Talks mHealth in CenterWatch Monthly

Deploying wearable devices in global clinical studies offer the promise of better, more cost-efficient data for clinical trial sponsors, but what about the infrastructure behind the massive volumes of data? Unreliable cell network coverage in certain markets? Wearables’ ability to collect reliable, validated endpoint data?

In a recent article in The CenterWatch Monthly, Medidata Principal of mHealth Joe Dustin discussed how trial sponsors are overcoming perceived challenges, but he also raised an interesting prospect for for global mHealth trials:

“In developing markets, traditional data collection can just be skipped. The idea of using digital endpoints and wearables is just what they’re starting with in many cases. That surprised me, [because] the primary markets I thought would be doing this were the U.S. and Europe, which is where everything starts.”

“Overall, the complexity of the changing regulation and laws around data privacy is impacting the globalization of clinical trials,” Joe continued. “It’s complicated depending on where you go but a lot of times it’s more a speed bump than a wall.”

About Author

Joe Dustin

Joe Dustin is the Principal of Mobile Health at Medidata. For 15 years, Joe has been leading efforts to transform the patient experience in clinical trials using mobile apps, wearables and biosensors. Joe started his career during the early days of ePRO and has held many roles in IT, Project Management, Support, and Solution Consulting. Previously, Joe worked at CRF Health and etrials before joining Medidata in 2008. Originally from the Boston area, Joe is passionate about technology, an avid guitar player, and has never experienced a clinical trial run on paper.